Sean Ekins on Regulating AI Drug Discovery

On this special episode of the podcast, Emilia Javorsky interviews Sean Ekins about regulating AI drug discovery. Timestramps: 00:00 Introduction 00:31 Ethical guidelines and regulation of AI drug discovery 06:11 How do we balance innovation and safety in AI drug discovery? 13:12 Keeping dangerous chemical data safe 21:16 Sean's personal story of voicing concerns about AI drug discovery 32:06 How Sean will continue working on AI drug discovery

Om Podcasten

The Future of Life Institute (FLI) is a nonprofit working to reduce global catastrophic and existential risk from powerful technologies. In particular, FLI focuses on risks from artificial intelligence (AI), biotechnology, nuclear weapons and climate change. The Institute's work is made up of three main strands: grantmaking for risk reduction, educational outreach, and advocacy within the United Nations, US government and European Union institutions. FLI has become one of the world's leading voices on the governance of AI having created one of the earliest and most influential sets of governance principles: the Asilomar AI Principles.